beta-blockers for hypertension increase risk for new-onset diabetes compared with nondiuretic antihypertensive agents

Belknap, Steven
March 2008
ACP Journal Club;Mar/Apr2008, Vol. 148 Issue 2, p12
Academic Journal
The article focuses on 14 randomized controlled trials (RCTs) investigating if beta blockers increase the risk for new-onset diabetes in patients with hypertension. Trials found out that in patients with hypertension, first-line therapy with beta blockers is associated with increased risk for new-onset diabetes but does not affect risk for death or myocardial infarction compared with angiotensin-converting enzyme inhibitors, angiotensin receptor blockers or calcium-channel blockers.


Related Articles

  • What is the best treatment for hypertension in African Americans? Rao, Shobha; Cherukuri, Manjula; Mayo, Helen G. // Journal of Family Practice;Feb2007, Vol. 56 Issue 2, p149 

    The article discusses the best treatment for hypertension in African Americans. According randomized controlled trials, hypertension in African Americans is best initiated with the low-sodium Dietary Approaches to Stop Hypertension diet and a thiazide-type diuretic. However, a calcium channel...

  • No new hypertension guidance until April.  // GP: General Practitioner;10/14/2005, p7 

    The article reports that a joint NICE and British Hypertension Society (BHS) guideline on the management of hypertension will not be produced for another six months. NICE and the BHS had said they would revise existing guidelines which give conflicting advice over the best treatment for...

  • MI survivors: Using drug therapies to protect the heart. Amidon, Thomas M. // Geriatrics;Oct95, Vol. 50 Issue 10, p26 

    Discusses the medical management of older heart attack survivors by the primary care physician. Use of beta and calcium blockade, nitrates, and thrombus prevention against the recurrence of ischemia and infarction; Use of angiotensin-converting enzyme (ACE) inhibitors for myocardial infarction...

  • Are Beta Blockers Effective First-line Treatments for Hypertension? Cayley Jr, William E. // American Family Physician;11/1/2007, Vol. 76 Issue 9, p1306 

    The article discusses a clinical issue regarding the use of beta blockers as first-line treatment for hypertension. It says that present evidence does not support the use of beta blockers as basic therapy for hypertension. It mentions that beta blockers were inferior to calcium channel blockers...

  • Why and How We Should Treat Elderly Patients with Hypertension? Aronow, Wilbert S. // Current Vascular Pharmacology;Nov2010, Vol. 8 Issue 6, p780 

    No abstract available.

  • Beta-Blocker More Successful than ACE or CCB in Reducing Blood Presure.  // Kidney;Jan/Feb98, Vol. 7 Issue 1, p16 

    Compares the effectiveness and tolerability of beta-blockers, angiotensin-converting enzyme inhibitor or calcium channel blockers in the treatment of essential hypertension. Response rate for hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment.

  • Difficulties in Achieving Arterial Hypertension Control. Sur, Genel; Sur, Maria; Kudor-Szabadi, Liana; Sur, Lucia // Romanian Journal of Medical Practice;2011, Vol. 6 Issue 2, p114 

    Objective: Our study aims to examine the effectiveness of arterial hypertension treatment on arterial pressure values in a group of people, by gender and age. Material and methods: We performed an analytical prospective study, from 2007 to 2009, that included 2266 people; 674 subjects (397 women...

  • Drug treatment of hypertension. Williams, Bryan // BMJ: British Medical Journal (International Edition);1/11/2003, Vol. 326 Issue 7380, p61 

    Editorial. Discusses drug treatment options for hypertension. Benefits of antihypertensive drugs; Differences between older drugs, such as thiazides or β blockers, and newer drugs, such as angiotensin converting enzyme (ACE) inhibitors or calcium channel blockers. Results of the...

  • Patterns of antihypertensive medication use in hemodialysis patients. Rahman, Mahboob; Griffin, Valerie // American Journal of Health-System Pharmacy;7/15/2004, Vol. 61 Issue 14, p1473 

    Studies the pattern of antihypertensive drug use in patients undergoing long-term hemodialysis therapy. Frequency of hypertension in the participants; Percentage of the patients that were prescribed with calcium-channel blockers, angiotensin converting enzyme inhibitors and beta-blockers;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics